PLN 590.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 627.08 Million EUR | 5.74% |
2022 | 594.91 Million EUR | 10.67% |
2021 | 537.58 Million EUR | 2.45% |
2020 | 524.74 Million EUR | -8.71% |
2019 | 574.83 Million EUR | 6.46% |
2018 | 539.97 Million EUR | 1.46% |
2017 | 532.19 Million EUR | 5.0% |
2016 | 506.87 Million EUR | 6.09% |
2015 | 477.76 Million EUR | 7.07% |
2014 | 446.21 Million EUR | -7.96% |
2013 | 484.79 Million EUR | -0.16% |
2012 | 485.58 Million EUR | 9.14% |
2011 | 444.91 Million EUR | 7.69% |
2010 | 413.14 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 164.42 Million EUR | -0.37% |
2024 Q1 | 164.05 Million EUR | -7.19% |
2023 Q3 | 142.73 Million EUR | -2.14% |
2023 Q4 | 176.76 Million EUR | 23.84% |
2023 FY | 629.05 Million EUR | 5.74% |
2023 Q1 | 158.18 Million EUR | 1.92% |
2023 Q2 | 145.84 Million EUR | -7.8% |
2022 Q1 | 144.18 Million EUR | -0.79% |
2022 Q2 | 141.48 Million EUR | -1.87% |
2022 Q3 | 154.05 Million EUR | 8.88% |
2022 Q4 | 155.19 Million EUR | 0.74% |
2022 FY | 594.91 Million EUR | 10.67% |
2021 Q2 | 128.06 Million EUR | -3.12% |
2021 FY | 537.58 Million EUR | 2.45% |
2021 Q3 | 132.01 Million EUR | 3.09% |
2021 Q4 | 145.33 Million EUR | 10.09% |
2021 Q1 | 132.17 Million EUR | 6.09% |
2020 Q4 | 124.59 Million EUR | -6.96% |
2020 Q2 | 124.59 Million EUR | -12.04% |
2020 Q1 | 141.64 Million EUR | -6.17% |
2020 FY | 524.74 Million EUR | -8.71% |
2020 Q3 | 133.91 Million EUR | 7.48% |
2019 Q3 | 144.65 Million EUR | 6.28% |
2019 Q4 | 150.95 Million EUR | 4.36% |
2019 Q2 | 136.11 Million EUR | -4.9% |
2019 Q1 | 143.11 Million EUR | -1.92% |
2019 FY | 574.83 Million EUR | 6.46% |
2018 Q3 | 129.88 Million EUR | -0.9% |
2018 FY | 539.97 Million EUR | 1.46% |
2018 Q2 | 131.06 Million EUR | -1.54% |
2018 Q1 | 133.1 Million EUR | -12.24% |
2018 Q4 | 145.91 Million EUR | 12.35% |
2017 Q3 | 118.89 Million EUR | -6.04% |
2017 Q2 | 126.53 Million EUR | -6.32% |
2017 Q1 | 135.07 Million EUR | -8.02% |
2017 Q4 | 151.68 Million EUR | 27.58% |
2017 FY | 532.19 Million EUR | 5.0% |
2016 Q2 | 128.72 Million EUR | 7.52% |
2016 FY | 506.87 Million EUR | 6.09% |
2016 Q1 | 119.72 Million EUR | -14.08% |
2016 Q4 | 146.84 Million EUR | 31.61% |
2016 Q3 | 111.57 Million EUR | -13.32% |
2015 Q1 | 124.61 Million EUR | 25.67% |
2015 Q2 | 121.95 Million EUR | -2.13% |
2015 FY | 477.76 Million EUR | 7.07% |
2015 Q4 | 139.35 Million EUR | 51.74% |
2015 Q3 | 91.83 Million EUR | -24.7% |
2014 FY | 446.21 Million EUR | -7.96% |
2014 Q2 | 123.32 Million EUR | 7.29% |
2014 Q4 | 99.16 Million EUR | -8.84% |
2014 Q3 | 108.78 Million EUR | -11.79% |
2014 Q1 | 114.94 Million EUR | -13.02% |
2013 Q3 | 109.88 Million EUR | -10.85% |
2013 Q4 | 132.14 Million EUR | 20.25% |
2013 FY | 484.79 Million EUR | -0.16% |
2013 Q1 | 119.49 Million EUR | -16.81% |
2013 Q2 | 123.26 Million EUR | 3.16% |
2012 Q4 | 143.64 Million EUR | 28.41% |
2012 Q2 | 118.55 Million EUR | 6.3% |
2012 Q1 | 111.52 Million EUR | -17.43% |
2012 FY | 485.58 Million EUR | 9.14% |
2012 Q3 | 111.86 Million EUR | -5.65% |
2011 FY | 444.91 Million EUR | 7.69% |
2011 Q4 | 135.06 Million EUR | 0.0% |
2010 FY | 413.14 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Celon Pharma S.A. | 174.34 Million PLN | -259.684% |